Substituted coumarins as potent 5-lipoxygenase inhibitors

被引:42
|
作者
Grimm, EL [1 ]
Brideau, C [1 ]
Chauret, N [1 ]
Chan, CC [1 ]
Delorme, D [1 ]
Ducharme, Y [1 ]
Ethier, D [1 ]
Falgueyret, JP [1 ]
Friesen, RW [1 ]
Guay, J [1 ]
Hamel, P [1 ]
Riendeau, D [1 ]
Soucy-Breau, C [1 ]
Tagari, P [1 ]
Girard, Y [1 ]
机构
[1] Merck Frosst Ctr Therapeut Res, Kirkland, PQ H9H 3L1, Canada
关键词
5-lipoxygenase; leukotrienene inhibitor; coumarin; structure-activity relationship;
D O I
10.1016/j.bmcl.2006.01.085
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Leukotriene biosynthesis inhibitors have potential as therapeutic agents for asthma and inflammatory diseases. A novel series of substituted coumarin derivatives has been synthesized and the structure-activity relationship was evaluated with respect to their ability to inhibit the formation of leukotrienes via the human 5-lipoxygenase enzyme. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2528 / 2531
页数:4
相关论文
共 50 条
  • [21] Scaffold-Hopping Cascade Yields Potent Inhibitors of 5-Lipoxygenase
    Hofmann, Bettina
    Franke, Lutz
    Proschak, Ewgenij
    Tanrikulu, Yusuf
    Schneider, Petra
    Steinhilber, Dieter
    Schneider, Gisbert
    CHEMMEDCHEM, 2008, 3 (10) : 1535 - 1538
  • [22] EICOSATETRAENEHYDROXAMATES - INHIBITORS OF 5-LIPOXYGENASE
    KERDESKY, FAJ
    HOLMS, JH
    SCHMIDT, SP
    DYER, RD
    CARTER, GW
    BROOKS, DW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1985, 190 (SEP): : 29 - MEI
  • [23] EICOSATETRAENEHYDROXAMATES - INHIBITORS OF 5-LIPOXYGENASE
    KERDESKY, FAJ
    HOLMS, JH
    SCHMIDT, SP
    DYER, RD
    CARTER, GW
    TETRAHEDRON LETTERS, 1985, 26 (18) : 2143 - 2146
  • [24] A NOVEL SERIES OF HIGHLY POTENT 5-LIPOXYGENASE INHIBITORS - 2-ARYLDIENYLBENZOXAZOLES
    KOSAKA, T
    OCHIAI, K
    OHBA, S
    WAKABAYASHI, T
    MUROTA, S
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (01) : 35 - 38
  • [25] BENZOXEPIN AND BENZOTHIEPIN DERIVATIVES AS POTENT, ORALLY-ACTIVE INHIBITORS OF 5-LIPOXYGENASE
    SATOH, Y
    LIBBY, AH
    POWERS, C
    KOWALSKI, TJ
    WHITE, DH
    KIMBLE, EF
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (04) : 549 - 552
  • [26] DESIGN AND SYNTHESIS OF 5-LIPOXYGENASE INHIBITORS
    STRASSER, M
    COOPER, P
    DEWALD, B
    PAYNE, T
    HELVETICA CHIMICA ACTA, 1988, 71 (05) : 1156 - 1176
  • [27] Benzoxazole and pyridinothiazoles as 5-lipoxygenase inhibitors
    Choo, Hea-Young Park
    Oh, Sei-Ryang
    Lee, Hyeong-Kyu
    Ann, Kyeongsup
    Han, Gyoonhee
    Kim, Joo-Heon
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 631 - 631
  • [28] 2-SUBSTITUTED 1-NAPHTHOLS - POTENT 5-LIPOXYGENASE INHIBITORS WITH TOPICAL ANTI-INFLAMMATORY ACTIVITY
    BATT, DG
    GALBRAITH, W
    HARRIS, RR
    MALOFF, BL
    MAYNARD, GD
    PETRAITIS, JJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1988, 196 : 130 - MEDI
  • [29] PSEUDOPEROXIDASE ACTIVITY OF 5-LIPOXYGENASE STIMULATED BY POTENT BENZOFURANOL AND N-HYDROXYUREA INHIBITORS OF THE LIPOXYGENASE REACTION
    RIENDEAU, D
    FALGUEYRET, JP
    GUAY, J
    UEDA, N
    YAMAMOTO, S
    BIOCHEMICAL JOURNAL, 1991, 274 : 287 - 292
  • [30] 5-lipoxygenase inhibitors for the treatment of COPD
    Kilfeather, S
    CHEST, 2002, 121 (05) : 197S - 200S